Qiagen to Fatten Protein Sample-Prep Business with $10M Nextal Acquisition

genomeweb
360dx

Qiagen to Fatten Protein Sample-Prep Business with $10M Nextal Acquisition

Jun 30, 2005

NEW YORK, June 30 (GenomeWeb News) - Qiagen plans to send $9.7 million to acquire privately held Nextal Biotechnology, a provider of sample-prep consumables for protein crystallization, Qiagen said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Real-Time Lassa Virus Genome Analysis Shows Increase in Cases Not Due to New Strain
OpGen Prices $3.2M Stock Offering
BioMérieux Q3 Revenues Grow 7 Percent
BGI Americas, Gencove Partner on Sequencing Service
Illumina Accelerator Program Adds Five Startups to Eighth Investment Cycle
Acute Myeloid Leukemia Analysis Brings Together Integrated 'Omic, Drug Response Profiles

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Main menu